The ready availability of high-quality, affordable active pharmaceutical ingredients (APIs) is critical to the delivery of good health to all.
The Dr. Reddy’s API business supplies high quality affordable APIs to leading generic formulations manufacturers across the world, enabling them to accelerate access to affordable medicines for patients worldwide. We are the preferred API partner to pharma companies across the US, Europe, Latin America, Japan, China, Korea and emerging markets.
Our business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAIs /oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards.
A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently, cost-optimally and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.
Our API business is supported by the Custom Pharmaceutical Services (CPS) arm, through which we support pharmaceutical companies across the value chain from development to manufacturing; and from intermediates and drug substances (APIs) to drug product (formulations). To learn more about our CPS business and how we can serve as your CDMO partner, please click here.
Sustainability and Social Responsibility
Our sustainability journey is geared towards creating lasting value for all our stakeholders - shareholders, employees, partners and society – without a trade-off on their mutual or individual interests. The processes that we deploy focus on eliminating waste and conserving natural resources like energy and water. All our plants are 'zero liquid discharge' facilities, which means that all the liquid waste and effluent they generate is treated within their premises and reused. We also co-processed/recycled 91 % of our total hazardous waste and continue to be on course to meet our target of zero hazardous waste to landfill by 2020.
Realizing our responsibility to the people of the communities that we live and work in, we pursue community care with the same efficiency and meticulousness with which we pursue our business to create real opportunities, building capabilities and empowering those who need them in areas of health, education and livelihoods. Please click here to read more